Skip to navigation Skip to content

Prevent

Share

Details

Washington University School of Medicine - John L. Trotter MS Center
660 S Euclid Ave.
St. Louis, MO 63110
See Map

Location of Trial: 
Washington University School of Medicine
John L. Trotter MS Center   
 
Name of Trial:  
Prevent
 
Description:  
The purpose of this study is to determine if eculizumab is safe and effective for preventing relapses in patients with relapsing NMO (Neuromyelitis Optica).
 
Participant Criteria:  (age, type of MS (if necessary):
1. Age: > 18 years old
2. Diagnosis of NMO or NMOSD
3. EDSS < 7 (Unable to walk approximately five meters even with aid, essentially restricted to wheelchair) 
4. For female participants, no desire for pregnancy during the study.
 
Length of Trial:
3 – 4 years
 
Clinical Trial Sponsor: 
Alexion Pharmaceuticals, Inc.
 
Contact: (Name, phone #, email):
Susan Fox, Research Patient Coordinator
314-362-2017
Neurology, Campus Box 8111
660 South Euclid Ave. 
 

Share


Chapter HomeReturn to list
© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.